Evidence map›Paper›PMID 38947266›Full record

ArticleWorld journal of orthopedics2024

Examining the "revisability" benefit of hip resurfacing arthroplasty.

Jose George, Adam J Taylor, Thomas P Schmalzried

Abstract read
In one paragraph

Article in World journal of orthopedics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jose GeorgeDepartment of Orthopedics, Harbor UCLA Medical Center, Torrance, CA 90509, United States. josegrg2019@gmail.com.
Adam J TaylorDepartment of Orthopedics, Harbor UCLA Medical Center, Torrance, CA 90509, United States.
Thomas P SchmalzriedDepartment of Orthopedics, Harbor UCLA Medical Center, Torrance, CA 90509, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHip resurfacing arthroplasty (HRA) is an alternative to total hip arthroplasty (THA) that is typically reserved for young active patients because it preserves bone. However, the benefits of HRA only hold true if conversion THA after failed HRA provides acceptable outcomes.

aimTo compare patient reported outcomes for conversion THA after HRA failure to primary THA.

methodsA retrospective review of 36 patients (37 hips) that underwent conversion THA for failed HRA between October 2006 and May 2019 by a single surgeon was performed. Patient reported outcomes [modified Harris Hip Score (mHHS), University of California Los Angeles (UCLA) activity score] were obtained

resultsThe study group had a lower mHHS than the control group (81.7 ± 13.8

conclusionPatient outcomes equivalent to primary THA can be achieved following HRA conversion to THA. However, inferior outcomes were demonstrated for ALTR-related HRA failure. Patient selection and perhaps further studies examining alternative HRA bearing surfaces should be considered.

Indexed as

Adverse local tissue reactionConversion total hip arthroplastyHip resurfacing arthroplastyPatient reported outcome measuresTotal hip arthroplasty

Identifiers

PMID38947266
PMCPMC11212540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.